Philips Focuses On Health Care And Lighting Business
This article was originally published in PharmAsia News
Executive Summary
As part of its ongoing transformation and restructuring, Philips has spent almost $20 billion on large-scale acquisitions in the health care and lighting sectors in recent years. Compared to the corporation's global market, Philips China has a lower ratio of health care and lighting business, thus it intends to expand the two areas. Inside sources explain that self-development will not allow the company to meet the two sectors' rapid growth, while acquisition can save time and scale up quickly. Philips will seek breakthrough in the mid- and low-end medical device market, which occupies some 75 percent of the China market. The Dutch company, GE and Siemens are leading players in the high-end medical device market. (Click here for more - Chinese language)
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.